FASCIOLIASIS

Clinical trials for FASCIOLIASIS explained in plain language.

Never miss a new study

Get alerted when new FASCIOLIASIS trials appear

Sign up with your email to follow new studies for FASCIOLIASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Liver fluke drug proves safe in largest study yet

⭐️ CURE ⭐️ Completed

This study tested the safety and effectiveness of the drug EGATEN (triclabendazole) in 301 people aged 6 and older with fascioliasis, a parasitic liver infection. Participants received two doses of EGATEN 12 hours apart and were followed for 90 days. The goal was to see if the dr…

Matched conditions: FASCIOLIASIS

Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: ⭐️ CURE ⭐️

Last updated Jun 27, 2026 12:37 UTC

FASCIOLIASIS

Get alerted when new FASCIOLIASIS trials appear

Liver fluke drug proves safe in largest study yet